www.fdanews.com/articles/138025-valeant-pharma-acquires-rights-for-skin-medications-in-us-canada-mexico
Valeant Pharma Acquires Rights for Skin Medications in US, Canada, Mexico
June 30, 2011
Valeant Pharmaceuticals International said Thursday it will pay $76 million plus additional royalties to acquire the marketing rights to skin medications Elidel and Xerese for the U.S., Canada and Mexico markets.
Winnipeg Free Press
Winnipeg Free Press